Echo Therapeutics, Inc. Share-based Payment Arrangement, Expense
Echo Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of $554.00 thousand for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2013-11-07
- Echo Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2013-09-30 was $98.00K, a 68.69% decline year-over-year.
- Echo Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2013-06-30 was $254.00K, a 103.20% increase year-over-year.
- Echo Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2013-03-31 was $202.00K, a 28.37% decline year-over-year.
- Echo Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2012-09-30 was $313.00K, a 12.19% increase year-over-year.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month |
|---|---|---|---|
| 2013-09-30 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $352.00K derived: sum of 2 quarters · filed 2013-11-07 | $554.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $254.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $456.00K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $202.00K 10-Q · filed 2013-05-10 | ||
| 2012-09-30 | $313.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $438.00K derived: sum of 2 quarters · filed 2013-11-07 | $720.00K 10-Q · filed 2013-11-07 |
| 2012-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $407.00K 10-Q · filed 2013-08-09 | |
| 2012-03-31 | $282.00K 10-Q · filed 2013-05-10 | ||
| 2011-09-30 | $279.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $566.00K 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $287.00K 10-Q · filed 2012-08-09 |